Drug- Receptor Interaction

Slides:



Advertisements
Similar presentations
What is Pharmacology? Pharmacology is the study of drugs It involves examining the interactions of chemical substances with living systems, with a view.
Advertisements

Introduction to Pharmacology
LAKSHMAN KARALLIEDDE OCTOBER 2011
DR. SHABANA ALI (Asso. Prof.) Kd- Dissociation constant.
Drug Chemistry and Toxicology CHE 618 Alexander Nazarenko.
DRUG-RECEPTOR INTERACTIONS
QUANTITATIVE ASPECTS OF DRUG ACTION
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Pharmacology-1 PHL 313 Fifth Lecture By Abdelkader Ashour, Ph.D. Phone:
Drug ? RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb 
Pharmacodynamics Chapter 2. Concentration/Response Relationship Can meas drug/ receptor binding directly –Ex: Radioimmunoassay Ex: radioactive drug binding.
Pharmacology-1 PHL 313 Fourth Lecture By Abdelkader Ashour, Ph.D. Phone:
Drug-Receptor Interactions Pharmacodynamics
Principles of Pharmacology: Pharmacodynamics

Receptor and Signal Transduction Receptor Concept Dept. Pharmacology, Tzu Chi Univ. T.H. Chiu I. References for the lecture II. Development of receptor.
Principles of Pharmacology: Pharmacodynamics
Section 1, Lecture 7 Pharmacodynamics
PHC 222 Part(I) Dr. Huda Al Salem Lecture (7). Factors that affect the efficacy 2- Concentration-Response Curves: Agonist Antagonist Partial agonist Desensetization.
 Receptors are mostly membrane-bound proteins that selectively bind small molecules called ligands which results in physiological response.  They are.
Pharmacology UG-Course Touqeer Ahmed PhD 19 th February, 2015 Atta-ur-Rahman School of Applied Biosciences National University of Sciences and Technology.
BASIC PHARMACOLOGY 2 SAMUEL AGUAZIM(MD).
RESPONSE altering their biochemical &/or biophysical activity  Depress  Activate  Replace  Irritate  Destroy PHARMACODYNAMICS  Absorb  Distribute.
HuBio 543 September 6, 2007 Frank F. Vincenzi
A protein binds a ligand through a specific, reversible interaction
Year One Pharmacodynamics
PHARMACODYNAMICS M.T. Piascik PHA 824 November 11, 2008.
At the end of this lecture, the students will be able to: 1.Define receptors 2.Define agonists 3.List types of agonists 4. Define antagonists 5. List.
Receptor Theory & Toxicant-Receptor Interactions Richard B. Mailman.
Dr. Laila M. Matalqah Ph.D. Pharmacology Pharmacodynamics 2 General Pharmacology M212.
415 PHT Plasma Level – Time Curve
Clinical Pharmacokinetics. Time course Duration Onset Absorptive phase Elimination phase.
DRUG RECEPTORS AND PHARMACODYNAMICS
QUANTITATIVE ASPECTS OF DRUG ACTION
Section 1, Lecture 8 Receptor Classification according to: -which drugs they interact with (  -adrenergic –binds norepinphine with high affinity.
INTRODUCTION Lecture 3. Pharmacodynamics Receptor: macromolecule that interacts with a drug and initiates the chain of biochemical events leading to the.
Dept. Pharmacology & Therapeutic Universitas Sumatera Utara
Pharmacodynamics What the drug does to the body?
To record DRC of Acetylcholine using rat ileum
QUANTITATIVE ASPECTS OF DRUG ACTION ilo s By the end of this lecture you will be able to :  Recognize different dose response curves  Classify different.
Pharmacodynamics. * The study of the biochemical and physiologic effects of drugs and the molecular mechanisms by which those effects are produced * The.
Affinity and Avidity by: Omar Ammar
Pharmacology-1 PHL 351 Abdelkader Ashour, Ph.D..
DRUG ANTAGONISM DR. SHABANA ALI.
Receptor Theory & Toxicant-Receptor Interactions
MBBS-BDS LECTURE NOTES
Tissue response compared to receptor occupation
5 Pharmacodynamics.
Drug-Receptor Interactions
INTRODUCTION to Pharmacology
Pharmacodynamics 2.
Pharmacology UG-Course
Drug-Receptor Interactions
Pharmacology UG-Course
Receptive substances proposed 1909 by Langley (nicotine)
Pharmacodynamic Dr. Hashem Mansour.
Introduction to Pharmacology
By Amany Helmy Hasanin Assistant Professor of Clinical Pharmacology
Lee E Limbird, Palmer Taylor  Cell 
Efficacy, Potency and Safety of Drugs
Drug ½ life time it takes plasma concentration or amount of drug in body to be reduced by 50% Provides a good indication of the time necessary to reach.
ANTAGONISTS Antagonists are substances which block the action of agonists There are a number of types COMPETITIVE NON-COMPETITIVE PARTIAL AGONISTS PHYSIOLOGICAL.
Drug-Receptor Interaction
Introduction to Pharmacology
Drug-Receptor Interactions and Pharmacodynamics (cont.)
How effective is an antagonist?
Relative potency of Drugs
Section 1. Basic Principles of Pharmacology
Drug-Receptor Interaction
Full agonists The “agonists” referred to so far are FULL AGONISTS
Presentation transcript:

Drug- Receptor Interaction

Drug-Receptor interaction I- Ka and Kd II- Dose response relationship III- Potency Understand Efficacy Agonist Antagonist

1 Kd = Ka Drug (D) + Receptor (R) (D) (R) complex Effect versely Rate of D binding affinity Ka = k1/k2 which is association constant K1 to R Drug (D) + Receptor (R) Effect (D) (R) complex Rate of DR complex to dissociation K2 Kd = k2/k1 or 1/Ka which is equilibrium dissociation constant or affinity constant 1 Kd = Ka versely •Kd value reflects affinity of a drug to bind to that receptor. •Kd is the concentration of that drug that will occupy 50% of a receptor Kd value and affinity are in related

when a drug has a low Kd. The binding of the ligand to the receptor is …S..t,rong and the affinity is …..High Affinity describes the strength of the binding between a ligand & its receptor. The  the affinity, the  the drug conc. required to occupy a receptors. Affinity is directly related to the potency of the drug (because it determine drug concentration) 1 Kd = Ka K2 The low Kd value, the the The higher the Kd value, the weaker the interaction and the lower the affinity Or higher interaction, K1 higher the affinity & the more potent drug K1 So if a drug has a high affinity for a receptor….., DR complex will be …… & value of Kd will be …S…mall

DRUG RESPONSE The magnitude of the response will be function of fractional occupancy of recep. & the total number of recep. occupied

DOSE-RESPONSE RELATIONSHIP This is the connection between the amount of a drug & the magnitude of the effect produced Characteristics of curve: Is the maximal effect of a drug Steep dose- response curve indicates that small change in dose produces a large change in drug effect X axis represent Dose Y axis represent response

DOSE-RESPONSE CURVE Hyperbolic curve Sigmoid curve permits display of a wide range of doses on a single graph Hyperbolic curve

1- GRADED DOSE-RESPO NSE CURVE sponse to  drug conc. or dose (the relationshi ation & the magnitude of the response). simple occupancy theory, but after time it was mo ug not linearly proportional to the percent of recepto cts could be produced by an agonist occupying o ay have varying capacities to initiate a response. esulted in the concepts of drug efficacy and p effects that can be determined from graded d NSE CURVE A graph of  re receptor occup At first there was a Response of dr Maximum effe receptors. Different drugs m These findings r properties for drug p between drug dose, dified due to: rs occupied. nly a small proportion of otency (two important ose response curve).

POTENCY Refers to the conc. (EC50) or dose (ED50) of a drug necessary to produce 50% of that drug's maximal response. Potency can be determined from either graded or quantal dose-response curves. The potency of a drug depends on: (1)Receptor affinity for binding the drug (Kd value) (2)The efficiency with which drug-receptor interaction is coupled to response

EFFICACY (E MAX, MAXIMAL EFFICACY) Refers to the maximal effect (magnitude of response) that can be achieved with a drug, regardless of dose. Efficacy can be measured with a graded dose-response curve but not with a quantal dose response curve. Efficacy depends on: The number of DR complexes formed The intrinsic activity of the drug The clinical effectiveness of a drug depends on its maximal efficacy (E max) not on its potency (EC50)

INTRINSIC ACTIVITY (INTRINSIC EFFICACY) Describes the ability of the bound drug to  conformational changes in the receptor (i.e effect of drugs on receptor). Although affinity is a prerequisite for drug binding to a receptor, a drug may bind with high affinity but have low intrinsic activity. A drug with zero intrinsic activity is an antagonist.

AGONIST Inverse Agonist Full Agonist Partial Agonist S + R S + R Large Drugs that interact with and activate receptors Inverse Agonist Full Agonist Partial Agonist n S + R S + R conformational changes in R to be active unable to produce a maximal response eve when it occupies all of the receptors Large effect effect •Drug has higher affinity for the inactive receptor form (R) than R* & also allow conversion of R* to R. has affinity but low intrinsic efficacy (<1) high affinity & high intrinsic efficacy (=1) e.g: buspirone, buprenorphine, pindolol and salbutamol Act by reverses the basal e.g: phenylephrine is an agonist at α1- adrenoceptors gives effect like NE. response of the system when it is due to spontaneous receptor activation (constitutive activity)

AGONIST

ANTAGONISTS Antagonists: drugs that  the actions of another drug or endogenous ligand. Antagonists bind to a receptor with high affinity & zero intrinsic activity There are 5 types

1-COMPETITIVE ANTAGONISTS: • Are drugs that bind to, reversible way without ac 1-COMPETITIVE ANTAGONISTS: or very close to, the agonist receptor site in a tivating the receptor. Note: If agonist is given in  conc., this fully activate the receptors & log do shifted to the right Example: atenolol is β1-adrenocep will displace competitive antagonist se response curve for an agonist will b tors antagonist & e